3641. Comments on "Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study".3642. Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014-2019.
作者: Haftom Legese.;Brhane Berhe.;Gebre Adhanom.;Tsega Kahsay.;Aderajew Gebrewahd.;Guesh Gebremariam.;Fitsum Mardu.;Kebede Tesfay.;Haftay Gebremedhin.;Hadush Negash.
来源: BMC Gastroenterol. 2023年23卷1期164页
Hepatitis B and C viruses are the major public health concerns of the globe. The two hepatotropic viruses share common modes of transmission and their co-infection is common. Despite the provision of an effective prevention mechanism, the infections caused by these viruses remain a significant problem worldwide, particularly among developing countries like Ethiopia.
3643. Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy.
作者: Hao Luo.;Chongming Huang.;Meng Meng.;Ming Zhang.;Zigang Li.;Jun Huang.
来源: BMC Gastroenterol. 2023年23卷1期162页
Prognosis determination is essential for hepatocellular carcinoma (HCC) patient management and treatment planning. The current study aimed to evaluate the prognosis performance of NLR, ALBI, and the combination of NLR-ALBI in determining the overall survival (OS) of HCC patients under curative hepatectomy.
3644. Clinical epidemiology and outcomes of patients with gastric intestinal metaplasia in the Los Angeles County System.
作者: Preeti Prakash.;Shailavi Jain.;Harry Trieu.;Kenneth Chow.;Deepthi Karunasiri.;Tom Liang.;Evan Yung.;Holli Mason.;Hongying Tan.;James H Tabibian.
来源: BMC Gastroenterol. 2023年23卷1期165页
Gastric intestinal metaplasia (GIM) is a precursor to gastric adenocarcinoma (GAC). In the United States, there is no consensus on the utility of surveillance for GIM, and minority populations most affected by GAC are understudied. Our aims were to define clinical and endoscopic features, surveillance practices, and outcomes in patients with GIM in a multicenter safety-net system.
3645. Changes in the salivary metabolome in patients with chronic erosive gastritis.
作者: Shaowei Liu.;Shixiong Zhang.;Haoyu Chen.;Pingping Zhou.;Tianxiao Yang.;Jingjing Lv.;Huixia Li.;Yangang Wang.
来源: BMC Gastroenterol. 2023年23卷1期161页
Chronic erosive gastritis (CEG) is closely related to gastric cancer, which requires early diagnosis and intervention. The invasiveness and discomfort of electronic gastroscope have limited its application in the large-scale screening of CEG. Therefore, a simple and noninvasive screening method is needed in the clinic.
3646. The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy.
Anti-hepatitis B virus (HBV) treatment uses tenofovir disoproxil fumarate (TDF) along with Pegylated-interferon-alpha (Peg-IFN-α), which is more effective than TDF/Peg-IFN-α monotherapy. We have previously shown that interleukin-1beta (IL-1β) is related to the effectiveness of IFN-α treatment in chronic hepatitis B (CHB) patients. The aim was to investigate the expression of IL-1β in CHB patients treated with Peg-IFN-α combination with TDF and TDF/Peg-IFN-α monotherapy.
3647. Severe combined immunodeficiency: improved survival leading to detection of underlying liver disease.
作者: Anusha Vittal.;Nehna Abdul Majeed.;Elizabeth Garabedian.;Jamie Marko.;David E Kleiner.;Rob Sokolic.;Fabio Candotti.;Harry Malech.;Theo Heller.;Christopher Koh.
来源: BMC Gastroenterol. 2023年23卷1期166页
Adenosine deaminase deficiency (ADA) is an autosomal recessive disorder leading to severe combined immunodeficiency (SCID). It is characterized patho-physiologically by intracellular accumulation of toxic products affecting lymphocytes. Other organ systems are known to be affected causing non-immune abnormalities. We aimed to conduct a cross sectional study to describe liver disease in autosomal recessive ADA-SCID.
3648. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
作者: Karishma Shelley.;Amy Articolo.;Rakesh Luthra.;Michael Charlton.
来源: BMC Gastroenterol. 2023年23卷1期160页
Nonalcoholic steatohepatitis (NASH) is the more severe, inflammatory type of nonalcoholic fatty liver disease (NAFLD). NASH, a leading indication for liver transplantation, is growing in prevalence. The extent of liver fibrosis, ranging from fibrosis stage (FS) of none (F0) to cirrhosis (F4), is a strong predictor of health outcomes. There is little information on patient demographics and clinical characteristics by fibrosis stage and NASH treatment outside of academic medical centers.
3652. The contribution of lysophosphatidic acid receptors in the response of human lower esophageal sphincter under the electrical field stimulation.
This study aims to identify the impact on the reaction while the clasp and sling fibers of the human lower esophageal sphincter are under the electrical field stimulation, by adding lysophosphatidic acid receptor subtypes antagonist.
3653. A postsurgical prognostic nomogram for patients with lymph node positive rectosigmoid junction adenocarcinoma.
The definition of rectosigmoid junction (RSJ) is still in debate. The treatment and prognosis of patients with rectosigmoid junction cancer (RSJC) and positive lymph nodes (PLN-RSJCs) are mostly based on the American Joint Committee on Cancer (AJCC) staging system. Our study aims to assist clinicians in creating a more intuitive and accurate nomogram model for PLN-RSJCs for the prediction of patient overall survival (OS) after surgery.
3654. Cancer in Patients With Familial Adenomatous Polyposis: A Nationwide Danish Cohort Study With Matched Controls.
作者: John Gásdal Karstensen.;Steffen Bülow.;Helle Højen.;Anne Marie Jelsig.;Niels Jespersen.;Klaus Kaae Andersen.;Mads Damsgaard Wewer.;Johan Burisch.;Hans Christian Pommergaard.
来源: Gastroenterology. 2023年165卷3期573-581.e3页
Familial adenomatous polyposis (FAP) is a hereditary disorder that predisposes patients to colorectal cancer (CRC). Prophylactic colectomy has greatly reduced the risk of CRC. However, new associations between FAP and the risk of other cancers have subsequently emerged. In this study, we assessed the risk of specific primary and secondary cancers among patients with FAP compared with matched controls.
3655. Predicting in-hospital mortality in patients with acute pancreatitis in the ED: a direct, retrospective comparison of four clinical and radiological prognostic scores.
作者: Michele D Spampinato.;Fabio Caputo.;Matteo Guarino.;Chiara Iantomasi.;Francesco Luppi.;Marcello Benedetto.;Benedetta Perna.;Andrea Portoraro.;Angelina Passaro.;Rinaldo Pellicano.;Roberto DE Giorgio.
来源: Minerva Gastroenterol (Torino). 2024年70卷2期147-157页
Acute pancreatitis can be a severe disease that significantly impacts patients' quality of life and outcome. The clinical course is variable and predictive scoring systems have a debated role in early prognosis. This study aims to compare the prognostic accuracy of Balthazar, BISAP, HAPS and SOFA scores in the prediction of in-hospital mortality in patients with acute pancreatitis.
3656. Apposition of Fibroblasts With Metaplastic Gastric Cells Promotes Dysplastic Transition.
作者: Su-Hyung Lee.;Ela W Contreras Panta.;David Gibbs.;Yoonkyung Won.;Jimin Min.;Changqing Zhang.;Joseph T Roland.;Se-Hoon Hong.;Yoojin Sohn.;Evan Krystofiak.;Bogun Jang.;Lorenzo Ferri.;Veena Sangwan.;Jiannis Ragoussis.;Sophie Camilleri-Broët.;Joseph Caruso.;Chira Chen-Tanyolac.;Michael Strasser.;Philippe Gascard.;Thea D Tlsty.;Sui Huang.;Eunyoung Choi.;James R Goldenring.
来源: Gastroenterology. 2023年165卷2期374-390页
Elements of field cancerization, including atrophic gastritis, metaplasia, and dysplasia, promote gastric cancer development in association with chronic inflammation. However, it remains unclear how stroma changes during carcinogenesis and how the stroma contributes to progression of gastric preneoplasia. Here we investigated heterogeneity of fibroblasts, one of the most important elements in the stroma, and their roles in neoplastic transformation of metaplasia.
3657. Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal cancer.
作者: Shouhan Feng.;Zeshi Li.;Mei Liu.;Qianwen Ye.;Tianhui Xue.;Bing Yan.
来源: BMC Gastroenterol. 2023年23卷1期156页
The preoperative serum levels of inflammatory mediators, including C-reactive protein (CRP), procalcitonin (PCT) and interleukin-6 (IL-6), have been demonstrated to be correlated with patient outcomes in colorectal cancer (CRC); however, the prognostic role of these levels has been less well-studied in postoperative settings.
3658. Glucose metabolic upregulation via phosphorylation of S6 ribosomal protein affects tumor progression in distal cholangiocarcinoma.
作者: Atsuro Fujinaga.;Teijiro Hirashita.;Yuka Hirashita.;Kumiko Sakai.;Masahiro Kawamura.;Takashi Masuda.;Yuichi Endo.;Masayuki Ohta.;Kazunari Murakami.;Masafumi Inomata.
来源: BMC Gastroenterol. 2023年23卷1期157页
The prognosis of distal cholangiocarcinoma (dCCA) remains poor; thus, the identification of new therapeutic targets is warranted. Phosphorylated S6 ribosomal protein indicates a mammalian target of rapamycin complex 1 (mTORC1) activity, and mTORC1 plays a central role in controlling cell growth and regulating glucose metabolism. We aimed to clarify the effect of S6 phosphorylation on tumor progression and the glucose metabolic pathway in dCCA.
3660. Peroral esophageal myotomy for esophageal motility disorders.
作者: Oscar V Hernández Mondragón.;Omar M Solórzano Pineda.
来源: Minerva Gastroenterol (Torino). 2023年69卷2期193-208页
The concept of third space endoscopy first described in 2007, was adapted and performed in humans in 2010 by Inoue et al. in a group of patients with esophageal achalasia (EA). Since then, esophageal endoscopic myotomy (E-POEM), has been performed in more than 10,000 patients worldwide up to now. Safety and efficacy have been confirmed at early, mid and long-term evaluations, in different gastrointestinal diseases including achalasia, refractory gastroparesis, and other esophageal motility disorders (EMD). Nowadays, this treatment has shown to be not only an excellent option, but also with its excellent outcomes, the first option in certain clinical scenarios such as type III achalasia. Thus, the minimal invasive nature of POEM gives us multiple advantages compared with the classical treatments that includes pneumatic dilation (PD) and laparoscopic Heller myotomy (LHM), including not only clinical aspects but also economical. High resolution manometry (HRM) has substantially redefined the actual approach of esophageal motility disorders with the major changes in instrumental use, diagnostic algorithms, and therapeutics. The previous Chicago's classification V 3.0 clearly improved our knowledge about pathophysiology of spastic esophageal motor disorders, however, with its recent update (Chicago V 4.0), multiple changes in diagnosis and treatment are expected. In the present article, we aimed to review and analyze the most important aspects about the results of E-POEM in the management of EMD according to the view of the new Chicago's classification V 4.0.
|